Regeneron Pharmaceuticals (REGN)

Free Cash Flow

$3.52B

TTM · Period ending: · USD

REGN logo

REGN Free Cash Flow

Latest reported$3.52B
REGN TTM Free Cash Flow (-$19.30M → $3.52B)
High-resolution chart · PNG

REGN free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
3,521,900,000
4,155,200,000
4,080,500,000
4,154,300,000
3,844,600,000
3,020,100,000
3,597,200,000
3,377,600,000
3,208,300,000
3,974,600,000
3,813,300,000
4,604,800,000
4,152,900,000
3,654,300,000
4,424,800,000
5,074,700,000
7,868,700,000
7,936,100,000
6,529,400,000
5,381,400,000
1,693,500,000
2,028,800,000
2,003,500,000
1,582,300,000
2,425,400,000
1,705,600,000
2,000,400,000
1,995,300,000
1,906,400,000
2,095,300,000
1,812,000,000
1,628,000,000
1,636,479,000
1,268,460,000
1,034,500,000
802,624,000
979,918,000
1,326,000,000
961,455,000
838,075,000
1,052,356,000
809,631,000
652,847,000
629,436,000
-32,766,000
214,835,000
419,429,000
546,601,000
522,813,000
350,985,000
427,325,000
297,543,000
224,149,000
39,189,000
-123,952,000
-263,581,000
-306,584,000
-264,249,000
-198,899,000
-211,254,000
-17,055,000
-3,347,000
-3,345,000
1,896,000
-168,823,000
-170,176,000
-169,548,000
-152,408,000
-171,129,000
-135,115,000
-123,943,000
-32,276,000
3,206,000
-1,583,000
8,926,000
20,934,000
20,878,000
5,197,000
20,264,000
-52,029,000
-53,295,000
-62,401,000
-35,260,000
-28,588,000
-17,774,000
28,257,000
-23,083,000
-39,271,000
25,053,000
-36,545,000
-35,789,000
-52,272,000
-142,868,000
-133,650,000
-144,893,000
-118,950,000
-110,436,000
-85,557,000
-65,543,000
-50,224,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.